Backgrounds Histamine participates in the immune regulation of several gastrointestinal diseases. However, the effect of histamine on intestinal intraepithelial lymphocytes (IELs), the front line of the intestinal mucosal immune system, is not well understood. We examined whether histamine has a direct effect on cytokine production by IELs and the involvement of histamine receptor subtypes. Methods Murine IELs were activated by PMA plus ionomycin with/without histamine. Secreted cytokines were measured and compared with those of splenocytes. Intracellular cytokines were detected by flow cytometry. Expression of histamine receptor subtypes in IELs was examined by RT-PCR.
Introduction
Histamine, one of the most intensively studied biological amines, is involved in the immune regulation of the inflammatory response of several gastrointestinal disorders, such as food allergy [1] , inflammatory bowel disease (IBD) [2, 3] , and irritable bowel syndrome (IBS) [4, 5] . Histamine exerts its effects through four receptors (H 1 R, H 2 R, H 3 R, and H 4 R), which are members of the G protein-coupled receptor (GPCR) family [6, 7] . Recent studies revealed that histamine regulates innate and acquired immune responses through H 1 R as well as H 2 R [8] and shifts the systemic Th1/Th2 balance from Th1 to Th2 [9, 10] .
Accumulating evidence suggests that histamine also affects gastrointestinal associated lymphoid tissue (GALT) and has an important role in the intestinal mucosal immune system. In the digestive tract, mast cells, basophils, and gastric enterochromaffin-like cells are the major source of ''granule-stored'' histamine, and recently the cells such as lymphocytes [11] , macrophages [12] , and colorectal cancer cells [13] , which have high L-histidine decarboxylase (HDC) activity, are also thought to be a source of ''inducible'' histamine. In patients with IBD, urinary excretion of the histamine metabolite N-methylhistamine is enhanced and is related to clinical and endoscopic disease activity [14] . H 1 R and H 2 R mRNA levels in the small intestine are significantly elevated in patients with food allergies and IBS [5] . Based on these observation and others, there is a speculation that not only H 1 R, but also H 2 R may be related for the dysregulation of the mucosal immunity [8, 15, 16] . Furthermore, in colorectal cancer, histamine modulates the Th1/Th2 balance and attenuates anti-tumor cytokine expression [17] . Several clinical trials have been carried out with H 2 R antagonists in colorectal cancer patients; both increased survival and immunological recognition of the tumor is reported [18] .
Intraepithelial lymphocytes (IELs) bear the front line of intestinal mucosal immunity and are phenotypically and functionally distinct from T cells in peripheral blood or the spleen [19] [20] [21] . Suggested functions for IELs are mediation of inflammatory reaction, surveillance of the intestinal epithelium, and induction or maintenance of oral tolerance [22, 23] . It is plausible for IELs to play a crucial role in the development and progression of the intestinal diseases. Studies indicate that IELs secrete several cytokines as immunoregulator cells in response to foreign antigens in vivo or stimulants in vitro [19, [24] [25] [26] [27] [28] [29] . Secreted cytokines vary according to the condition of the stimulation. In murine IELs, IFN-c and IL-5 are produced spontaneously and enhanced by stimulation [24] . Other studies shown that IFN-c, TNF-a, TGF-b1, IL-2, IL-3, and IL-6 are produced in CD8
? IELs by anti-TCR mAb stimulation [25] . Yet, there are few reports studying how IELs are regulated, and no study has examined the regulatory effects of histamine on IEL function.
The aim of this study was to determine whether histamine contributes to regulate intestinal mucosal immune responses mediated by IELs. We examined whether histamine has direct effects on conventional Th1-or Th2-cytokine production by IELs in vitro and whether different effects are mediated by the different histamine receptor subtypes. Further, we determined which IEL subsets were involved in IFN-c production by detecting intracellular cytokine production.
Materials and methods

Mice
Male C3H/HeN mice were obtained from Japan SLC (Hamamatsu, Japan) and were maintained under specific pathogen-free conditions. All mice in this study were used at 7-10 weeks of age and were allowed free access to food and water ad libitum. All experiments were performed according to the guidelines and regulations for Laboratory Animal Care of Hamamatsu University School of Medicine.
Materials
Phorbol myristate acetate (PMA), ionomycin, lipopolysaccharide (LPS) from Escherichia coli (serotype 026:B6), histamine dihydrochloride, pyrilamine maleate salt, famotidine, thioperamide maleate salt, and RPMI-1640 were purchased from Sigma (St. Louis, MO). Dimaprit was purchased from Wako (Osaka, Japan). Fetal bovine serum (FBS) and Hank's balanced salt solution (HBSS) were purchased from Gibco (Grand Island, NY). Percoll was purchased from Amersham/GE Healthcare Biosciences (Little Chalfont, UK). PE-labeled anti-mouse TCRb chain, FITC-labeled anti-mouse TCRcd, FITC-labeled anti-mouse CD3, PE-labeled anti-mouse CD4, PerCP-labeled antimouse CD4, PE-labeled anti-mouse CD8a, PE-labeled CD11c, PE-labeled anti-mouse CD14, FITC-labeled anti-mouse IFN-c, and PE-labeled anti-mouse IL-4 were purchased from BD PharMingen (San Diego, CA).
Phorbol myristate acetate and ionomycin were dissolved in dimethyl sulfoxide (DMSO) and diluted in RPMI-1640. Residual DMSO was \0.5% in culture medium. The other reagents such as histamine ligands and LPS were diluted in Milli Q water, and the stock solutions were stored at -20°C until use.
Isolation of IELs and preparation of splenocytes
Intraepithelial lymphocytes were isolated from the small intestine according to a previously reported method [30] with a minor modification [31] . Briefly, the small intestine was cut into pieces and stirred at 37°C for 45 min in HBSS containing 5% FBS. Supernatants containing IELs were filtered through a glass wool column before centrifugation through a 44/70% percoll gradient. IELs at the interface were collected, washed, and then resuspended in culture medium (RPMI-1640 supplemented with 10% FBS).
The spleen was removed from sacrificed mice and cut into several pieces. The cell suspension was then centrifuged, and the cell pellet was resuspended in Dulbecco's phosphate buffered saline. The red blood cells were lysed in lysing buffer (NH 4 Cl 150 mM, KHCO 3 1 mM, EDTA 0.01 mM). Splenocytes were washed two times and resuspended in the culture medium (RPMI-1640 supplemented with 10% FBS).
Analysis of H 1 R, H 2 R, H 3 R, and H 4 R mRNA expression on IELs
The mRNA expression of histamine receptor subtypes in IELs was detected by conventional reverse transcriptasepolymerase chain reaction (RT-PCR). Isolation of total RNA was performed using RNeasy mini kit (QIAGEN, Hilden, Germany) with DNase treatment (Ambion, Austin, TX). After DNase treatment, reverse transcription was performed using random hexamer primers (TaKaRa BIO, Otsu, Japan) and M-MLV (TaKaRa BIO The surface phenotypes of IELs and splenocytes were analyzed using fluorescence-labeled anti-mouse mAbs. Cells were stained with mAbs for 15 min on ice and washed in PBS. Cells were examined using an EPICS XLII System (Beckman Coulter, Fullerton, CA).
Analysis of secreted cytokines by cytometric bead array Cells were adjusted to a concentration of 1 9 10 6 cells/ml in culture media, pretreated with or without histamine ligands and incubated for the indicated time at 37°C in a humidified atmosphere of 5% CO 2 in air with or without PMA (40 ng/ml) plus ionomycin (4 lg/m), or LPS (1 lg/ ml). The supernatants were collected at 48 h after incubation in IELs and at 24 h after incubation in splenocytes, respectively, and IFN-c, TNF-a, IL-2, IL-4, IL-5, and IL-10 were detected using the mouse cytometric bead array (CBA) kit (BD PharMingen). The CBA kit employs a series of beads with discrete fluorescence intensities that enable us to simultaneously detect multiple soluble cytokines. Each bead provides a capture surface for a cytokine and is analogous to a coated well in an enzyme-linked immunosorbent assay.
Analysis of intracellular cytokines
Cells were adjusted to a concentration of 1 9 10 6 cells/ml in culture media, pretreated with or without histamine (10 -4 M), and incubated with PMA (40 ng/ml) plus ionomycin (4 lg/ml) and brefeldin A (20 lg/ml) for 4 h at 37°C in a humidified atmosphere of 5% CO 2 in air. Intracellular IL-4 and IFN-c were detected in fixed and permeabilized cells using mAbs conjugated to PE or FITC. Data were acquired by flow cytometry using an EPICS XLII System.
Administration of histamine agonists and antagonists
To assess the effects of histamine via histamine receptor subtypes, we used the H 1 R antagonist pyrilamine (10 -5 M), the H 2 R antagonist famotidine (10 -5 M), and the H 3 R/H 4 R antagonist thioperamide (10 -5 M) in the presence of histamine (10 -4 M). The selective H 2 R/H 4 R agonist dimaprit (10 -4 M) was used for the further confirmation of H 2 R selectivity with or without famotidine (10 -5 M). These doses were chosen based on pharmacological characteristics according to previous studies in nonimmune cells [32] and also immune cells, i.e., splenocytes [8, 10] , and we did not observe any cell toxicity of these agents based on a trypan blue assay.
Statistical analysis
The Student's t test was used for comparisons of secreted cytokine production between the control and stimulation groups with PMA plus ionomycin or LPS. To examine the effects of histamine, the data are shown as a percentage of each level in the presence of PMA plus ionomycin without any histamine receptor ligand and represent the mean ± standard error of the mean. Comparison between IFN-c producing TCRab
? and TCRcd ? population was statistically analyzed with the Student's t test. A level of P \ 0.05 was considered to be statistically significant.
Results
Purity and phenotypic characterization of IELs
Cell viability, determined by trypan blue exclusion, of purified IELs and splenocytes were [93 and [95%, respectively. Cell purity of the IELs compartment assessed by flow cytometry was 80.2 ± 4.7% ( Fig. 1 ), similar to the previous report [33] . To examine the phenotypic characteristics of purified IELs, we stained IELs with mAbs for the cell surface markers. Most IELs were CD3
? T cells (88.2 ± 3.2%, n = 3) and predominantly expressed CD8 (85.6 ± 0.9%) compared with CD4 (9.1 ± 0.7%). IELs contained CD4
? CD8 ? double positive cells (4.0 ± 1.0%) and CD11c
? cells (7.9 ± 0.1% ? cells (1.9 ± 0.6%).
Profile of cytokine production derived from IELs compared with splenocytes
We compared cytokine production by IELs and splenocytes activated with or without either PMA plus ionomycin or LPS. As shown in Table 1 , there was low cytokine production in the absence of stimulants (control group) both in IELs and splenocytes. Different profiles of cytokine production were observed between IELs and splenocytes in the presence of stimulants. Although IELs produced significantly higher levels of Th1-cytokines (IFN-c, TNF-a, IL-2) and IL-4 when activated by PMA plus ionomycin, LPS did not yield any inducible cytokines. On the other hand, splenocytes did produce IFN-c and TNF-a by the activation by LPS as well as PMA plus ionomycin, while the production level was different between the two conditions. Therefore, we subsequently used PMA plus ionomycin for the following experiments.
Detection of H 1 R, H 2 R, H 3 R, and H 4 R mRNA expression on IELs
To elucidate the expression of known subtypes of histamine receptor in IELs, we examined RT-PCR to detect the H 1 R, H 2 R, H 3 R, and H 4 R mRNA. As shown in Fig. 2 , H 1 R, H 2 R, and H 4 R mRNA were expressed on IELs, while H 2 R mRNA expression seems to be more substantial compared to the expression of H 1 R and H 4 R mRNA. We did not observe any signal for H 3 R mRNA.
Histamine decreases IFN-c, TNF-a, IL-2, and IL-4 derived from activated IELs as well as splenocytes
To determine whether histamine has regulatory effects on cytokine production in IELs, we examined the cytokines in the presence or absence of histamine compared with in splenocytes. Both in IELs and splenocytes, without PMA plus ionomycin stimulation, histamine had no apparent stimulatory effects on production of these cytokines (data not shown). When the IELs were activated by PMA plus ionomycin, histamine significantly decreased IFN-c, TNFa, IL-2, and IL-4. The inhibitory effect of IFN-c, TNF-a, These experiments were performed three times with similar results. Side scatter (SS) depends on the inner complexity of the particle, and forward scatter (FS) correlates with the cell volume IL-2, and IL-4 was 41, 48, 39 and 32%, respectively at 10 -4 M histamine. These effects were also observed in splenocytes; the inhibitory effect of IFN-c, TNF-a, IL-2, and IL-4 was 30, 46, 49, and 16%, respectively (Fig. 3) . Dose-dependent effects by histamine, between 10 -7 and 10 -4 M, were observed in Th1-cytokine (IFN-c, TNF-a, and IL-2) production, but not in IL-4 in IELs, which was secreted at a relatively low level.
Suppressive effects of histamine on Th1-cytokine and IL-4 secretion in IELs were mediated predominantly via H 2 R To determine the functional selectivity of histamine receptor subtypes on the histamine-mediated regulation of cytokine production, we examined the effects of selective histamine receptor antagonists on histamine treatment in IELs compared with splenocytes. We used the following selective antagonists for our experiments: pyrilamine for H 1 R, famotidine for H 2 R, and thioperamide for H 3 R/H 4 R [32] . Selective histamine receptor antagonists did not influence cytokine production by themselves, while the cells were activated by PMA plus ionomycin (data not shown). Then, cells were pretreated with pyrilamine (10 -5 M), famotidine (10
for 5 min and thereafter treated with histamine (10 -4 M) according to previous reports [8, 9, 34] . As shown in Fig. 4 , in IELs, only famotidine blocked the suppressive effect of histamine and restored the cytokine response on Th1-cytokine (IFN-c, TNF-a, and IL-2) and IL-4 comparable to the levels without histamine treatment. In splenocytes, the restorable effect of famotidine was not observed on IL-4, and minute effects were observed on Th1-cytokine compared to those in IELs.
To further confirm whether H 2 R signaling regulates cytokine production, we examined the effect of a selective agonist on IEL or splenocyte-derived IFN-c, TNF-a, IL-2, and IL-4 production. As shown in Fig. 5 , dimaprit (10 -4 M), a selective H 2 R/H 4 R agonist, mimicked the suppressive effect of histamine on this cytokine production derived from both IELs and splenocytes. Famotidine almost completely eliminated the effects of dimaprit on IEL-derived cytokine production. In splenocytes, the restorable effects by famotidine on the dimaprit-mediated effects on cytokine production were also significant; however, the restorations were rather small compared to those in IELs (Fig. 5) .
Histamine decreases the number of INF-c producing TCRab
? cells estimated by intracellular cytokine production in IELs
We examined whether the effects of histamine on cytokine secretion were also seen in intracellular cytokine production by IELs. Representative dot plots of intracellular IFN-c/IL-4 staining performed after 4 h are shown in Fig. 6a . IFN-c-producing cells were detected in IELs activated by PMA plus ionomycin, whereas IL-4 producing cells were too few (0.1%) for further evaluation. The number of IFN-c-producing cells decreased in the total IEL population when treated with histamine (Fig. 6b) , and the number of IFN-c-producing cells significantly decreased in the TCRab ? IEL population when treated with histamine (Fig. 6b) .
Suppressive effects of histamine on Th1-cytokine and IL-4 do not accompany enhancement of IL-10 production in IELs
Since it is well known that an increase of IL-10 induces peripheral T cell tolerance [15] and previous studies have revealed that histamine increases IL-10 secretion via H 2 R in DC [35] , Th2 cells and splenocytes [10] , we examined whether suppressive effects of histamine on Th1-cytokine and IL-4 are accompanied by enhancement of IL-10 production in IELs. IELs certainly produced significantly higher levels of IL-10 when activated by PMA plus ionomycin, compared to no stimulation control (261.7 ± 48.3 vs. 53.3 ± 24.0 pg/ml). Unexpectedly, histamine had no effect on the secreted IL-10 level in activated IELs (Fig. 7) . Further, in splenocytes there is no significant increase of secreted IL-10 when treated by PMA plus ionomycin and also no significant effect with histamine.
Histamine reduced IFN-c mRNA expression, but not IL-10 mRNA expression in IELs
To evaluate the mechanism underlying histamine-mediated cytokine suppression, the cytokine mRNAs levels were also tested to learn whether the expression was modulated by histamine under stimulation. We examined real-time PCR to reveal the IFN-c and IL-10 mRNA expression in IELs. As shown in Fig. 8 , histamine significantly decreased the IFN-c mRNA expression in activated IELs by PMA plus ionomycin at 6 h incubation, although the difference with/without histamine at 24 h incubation turn out to be small. On the contrary, IL-10 mRNA expression levels were not modulated by histamine treatment. These results suggested that the regulation of cytokine production by histamine is attained at the mRNA level.
Discussion
In this study, we examined for the first time whether histamine has a direct effect on cytokine production in murine IELs in vitro. Our main findings were that histamine decreased IEL-derived Th1-cytokine production and also decreased IL-4 production at a low level. These suppressive effects of histamine did not accompany enhancement of IL-10 production. A selective H 2 R antagonist (famotidine), but not H 1 R and H 3 R/H 4 R antagonists, competed with those suppressive effects of histamine. The effects of histamine were mimicked by a selective H 2 R/H 4 R agonist (dimaprit), and the effects of dimaprit were also competed with by famotidine. Our findings indicated that the suppressive effects of histamine on Th1-cytokine and IL-4 secretion in IELs were mediated predominantly via H 2 R signaling. Further, we found the number of IFN-c producing cells significantly decreased in TCRab ? IEL population when treated with histamine, and also the expression of IFN-c significantly decreased in histaminetreated IEL. The cytokine production by histamine was supposed to be attained at the mRNA level.
IELs arise from both thymic-dependent and thymicindependent sources, and they are phenotypically and functionally distinct from the T cells of peripheral blood or the spleen [20, 36] . As for the stimulation of IELs, we have tested PMA plus ionomycin and LPS. We also intended to use anti-CD3; experiments fail to show enough stimulatory reaction, and variations among the experiments were too high to evaluate the effect of histamine and its ligands (data not shown). Although it is well known that LPS activates many cultured cells, including peripheral blood monocytic cells, we found that LPS did not have an effect on the IELderived cytokines tested. While splenocytes are composed not only of T cells and B cells, but also antigen-presenting cells (APCs) such as macrophages and dendritic cells, which express TLR4 [37] , IELs are considered not to express TLR4. Previous studies have shown that histamine regulates monocytes, dendritic cells, T cells, and B cells in lymphatic organs and subepithelial tissues, and different effects have been observed among these cell types [38] . In APCs, H 1 R and H 3 R signaling induces proinflammatory activity and increased APC capacity, whereas H 2 R signaling plays a suppressive role on monocytes [39] and monocyte-derived dendritic cells (DCs) [16, 35, 40] . In peripheral T cells, histamine enhances Th1-type responses by triggering H 1 R, whereas both Th1-and Th2-type responses are negatively regulated by H 2 R [8] . These distinct effects suggest roles for H 1 R in autoimmunity and H 2 R in peripheral tolerance. In the digestive tract, the expression of H 1 R, H 2 R, and H 4 R mRNA in the mucosa was reported [5] . These reports did not distinguish between IELs and other kind of cells, such as enterocytes or LPLs. Our findings verify that dominantly H 2 R, but also H 1 R and H 4 R mRNA is expressed on murine IELs along with the facts demonstrating immunological response in case of H 2 R.
In this study, histamine suppressed Th1-cytokines and IL-4. H 2 R-dependent effects of Th1-cytokine and IL-4 suppression in IELs are similar to those of peripheral T cells that were previously reported [8, 41] . These effects may be the reflection of the functional characteristics of T cell tolerance in mucosal epithelium as IELs are crucial for the mucosal response to foreign antigens. Increase of IL-10 is well known to induce peripheral T cell tolerance [15] . Since earlier reports have revealed histamine-enhanced IL-10 secretion through H 2 R in monocytes, DCs, PBMC, and splenocytes [9, 10, 35, 40] , we examined whether the secreted IL-10 level in IELs was also affected by histamine. Contrary to our prediction, there are significant differences in IL-10 production in IELs compared to that of splenocytes. The suppressive effects of histamine did not accompany enhancement of IL-10 production or IL-10 mRNA expression in IELs. Our findings suggested that the other mechanisms may exist to suppress the cytokine production for T cell tolerance in IELs. Since the former report [42] suggested that the adherent cells were the key modulators of histamine-mediated effects on IL-10 production in splenocytes, a small amount of IL-10 production in the current experiments was perhaps due to different conditions of the cell stimulation, i.e., without adherent cells in our study.
In the present study, H 1 R, H 3 R, or H 4 R-mediated regulation of IEL cytokine production was not observed. H 2 R antagonists are widely used to treat acid-related diseases, such as peptic ulcer and reflux esophagitis. It is possible that H 2 R antagonists may affect the clinical course of certain gastrointestinal diseases by way of regulating the local mucosal immunity rather through the systemic immune regulation. Enhancement of inflammatory cytokines and Th1/Th2 dysregulation are present in the intestinal T cells of patients with Crohn's disease [43] . Since the suppressive effect of histamine on the IELs is more remarkable in the Th1 cytokines rather than Th2, it is possible that histamine may have a protective effect on the inflammation of Crohn's disease, which is known to be Th1-polarized [44, 45] .
Upregulation of histamine and histidine decarboxylase are known to occur in colorectal cancers [13] . Endogenous histamine in colon cancer tissues suppresses local tumor immunity and promotes tumor growth via H 2 R signaling [46] .The H 2 R antagonist famotidine enhances lymphocytic infiltration in colorectal cancer [47] , and cimetidine attenuates experimental tumor growth [48] . Further, some clinical studies have found survival benefits by administering H 2 R antagonists for the treatment of colorectal cancer [49] [50] [51] . Given that IELs are crucial for immune surveillance of the intestinal epithelium [22, 23] , direct regulation of IELs by histamine would be associated with the suppression of apoptosis of tumor cells. In this study, we also examined whether the effects of histamine on cytokines were reflected in the intracellular cytokine production by IELs. Whereas there were too few IL-4-producing cells to evaluate the effect of histamine, IFN-c-producing cells were significantly reduced by treatment with histamine. Since IELs are heterogenous with regard to their phenotype and function [22] , we further determined which cell subsets produced this cytokine. We found that almost all of the IFN-c-producing cells were TCRab ? cells, but not TCRcd ? cells. This suggests that there are functional differences with regard to the cytokine production in IEL subsets, whereas earlier studies reported that TCRcd ? cells produced IFN-c [19, 24, 25] . In the previous study, cells were stimulated by anti CD3 mAb, anti TCRab mAb, or anti TCRcd mAb [25] .
There are some limitations in this study. Our findings of a regulatory effect by histamine on IELs were only observed in the particular condition of stimulated PMA plus ionomycin in vitro, which is a generally recognized method to activate lymphocytes via protein kinase C pathway and calcium-dependent mechanisms. The purified IELs are relatively fragile when assessing their functional characteristics, and it is more difficult to examine their secreted cytokines than the other leucocyte's compartments, such as PBMCs and splenocytes. Therefore, further examination in gastrointestinal disease models in vivo may be required to determine the extent of effects of our findings.
In summary, we have presented the basic mechanism of histamine-mediated immunoregulation of IELs in vitro. Histamine has a direct suppressive effect on IELderived Th1-cytokines and IL-4, which may have an important role in the local immunoregulation of the intestinal epithelium. The inhibitory effects of histamine on Th1-cytokines in IELs were mediated predominantly via H 2 R signaling. Although further study is required to clarify the role of histamine-mediated immunoregulation in the intestinal mucosa in vivo, our findings would help to account for an important regulatory mechanism by endogenous histamine for the control of mucosal inflammatory functions in several gastrointestinal diseases. 6 cells/ml, treated with or without histamine (10 -4 M) in the presence of PMA plus ionomycin and incubated for 6 or 24 h. Cytokine mRNA levels are normalized to b-actin from the same sample. The data represent the mean ± SEM in three independent experiments performed in triplicate. *P \ 0.05
